Invention Grant
- Patent Title: Use of IGFBP-7 in the assessment of heart failure
-
Application No.: US16598361Application Date: 2019-10-10
-
Publication No.: US10996229B2Publication Date: 2021-05-04
- Inventor: Ursula-Henrike Wienhues-Thelen , Georg Hess , Hendrik Huedig , Herbert von der Eltz , Andrew Emili , Anthony Gramolini , Peter Liu , David MacLennan , Vincent Fong , Ruth Isserlin , Thomas Kislinger , Dirk Block
- Applicant: Roche Diagnostics Operations, Inc. , The Governing Council of the University of Toronto
- Applicant Address: US IN Indianapolis; CA Toronto
- Assignee: Roche Diagnostics Operations, Inc.,The Governing Council of the University of Toronto
- Current Assignee: Roche Diagnostics Operations, Inc.,The Governing Council of the University of Toronto
- Current Assignee Address: US IN Indianapolis; CA Toronto
- Agency: Dinsmore & Shohl LLP
- Priority: EP07001582 20070125
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/68
Abstract:
Disclosed is a method for assessing heart failure in vitro including the steps of measuring in a sample the concentration of the marker IGFBP-7, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for IGFBP-7 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of IGFBP-7 as a marker protein in the assessment of heart failure, a marker combination comprising IGFBP-7 and a kit for measuring IGFBP-7.
Public/Granted literature
- US20200064359A1 USE OF IGFBP-7 IN THE ASSESSMENT OF HEART FAILURE Public/Granted day:2020-02-27
Information query
IPC分类:
